Indiana University School of Optometry Continuing Education Plaquenil Toxicity Detected Without Bull's Eye Maculopathy
		Author: Julie Torbit, OD CE credit: 1 hour Cost: $25 In the United States, antimalarial drugs such as Plaquenil (hydrochloroquine) are used primarily for their anti-inflammatory effects in the treatment of auto-immune conditions (e.g., rheumatoid arthritis, lupus). It is estimated that approximately 3% of patients taking Plaquenil develop toxicity.2 The case presented involves a patient taking Plaquenil who did not show signs of Bull's eye maculopathy but who did exhibit abnormal ancillary test results. The Course Patient History and Examination Management Antimalarial Drugs Bull's Eye Maculopathy Testing for Toxicity Risk Factors and Follow-Up Frequency References Course Certification Examination URL: http://www.opt.indiana.edu/ce/plaq/index.htm Revised: May 7, 2007 IU Optometry home page: http://www.opt.indiana.edu/ Comments (content): Dr. Julie Torbit at jtorbit@indiana.edu Comments: Web Administrator Page design and coding: Terri Greene Copyright © 2007, The Trustees of Indiana University